Ryzhko V V, Andreeva N E, Gorodetskiĭ V M, Konovalova V I, Aleksanian M Zh, Sinitsina T V
Ter Arkh. 1990;62(7):59-63.
The paper is concerned with the use of plasmapheresis, lymphocytapheresis, lymphocytaplasmapheresis and plasma perfusion in patients with tumors of the lymphoid tissue. Based on 976 plasmapheresis sessions given to 161 patients the authors demonstrate its efficacy in the treatment of patients with tumors of the lymphoid tissue associated with secretion of paraprotein whose presence gives rise to such complications as the syndrome of high viscosity, cryoglobulinemia, chronic renal failure, amyloidosis, cold hemolytic disease and other paraproteinemia-induced complications. On abundant material (535 sessions given to 98 patients) the authors review situations in which lymphocytapheresis, lymphocytaplasmapheresis and plasma perfusion may be indicated. Consider approaches to their performance as well as the clinical efficacy of the methods.
本文关注血浆置换、淋巴细胞去除术、淋巴细胞血浆置换术和血浆灌注在淋巴组织肿瘤患者中的应用。基于对161例患者进行的976次血浆置换治疗，作者证明了其在治疗与副蛋白分泌相关的淋巴组织肿瘤患者中的有效性，副蛋白的存在会引发诸如高粘滞综合征、冷球蛋白血症、慢性肾衰竭、淀粉样变性、冷凝集素血症和其他副蛋白血症引起的并发症等。作者根据丰富的资料（对98例患者进行的535次治疗）回顾了可能需要进行淋巴细胞去除术、淋巴细胞血浆置换术和血浆灌注的情况。考虑了这些治疗方法的实施途径及其临床疗效。
